Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -38.87M
March 31, 2026 15.80M
December 31, 2025 45.95M
September 30, 2025 -12.82M
June 30, 2025 -45.18M
March 31, 2025 -38.54M
December 31, 2024 -24.49M
September 30, 2024 -25.75M
June 30, 2024 -20.78M
March 31, 2024 -38.42M
December 31, 2023 -17.58M
September 30, 2023 -27.98M
June 30, 2023 -33.99M
March 31, 2023 -46.00M
September 30, 2022 -30.74M
June 30, 2022 -41.81M
March 31, 2022 -20.76M
December 31, 2021 -5.541M
Date Value
September 30, 2021 -29.09M
June 30, 2021 -26.84M
March 31, 2021 -4.282M
December 31, 2020 -39.80M
September 30, 2020 -28.98M
June 30, 2020 -15.80M
March 31, 2020 -16.42M
December 31, 2019 -26.72M
September 30, 2019 -20.43M
June 30, 2019 -22.84M
March 31, 2019 81.05M
December 31, 2018 -20.35M
September 30, 2018 -12.05M
June 30, 2018 -19.14M
March 31, 2018 -18.61M
September 30, 2017 -7.380M
June 30, 2017 -7.222M
March 31, 2017 -8.133M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Xencor, Inc. -56.20M
UroGen Pharma Ltd. -35.08M
Ironwood Pharmaceuticals, Inc. 58.28M
Viking Therapeutics, Inc. -125.17M
IDEAYA Biosciences, Inc. -89.08M